Subcutaneous Implantable Cardioverter-Defibrillator Therapy for Secondary Prevention After Heart Transplantation: Is It Practical for All Patients?

Journal of Cardiothoracic and Vascular Anesthesia - United Kingdom
doi 10.1053/j.jvca.2017.08.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

An Entirely Subcutaneous Implantable Cardioverter–Defibrillator

New England Journal of Medicine
Medicine
2010English

Implantable Cardioverter Defibrillator Therapy During Pregnancy

Circulation Journal
MedicineCardiovascular MedicineCardiology
2013English

Prophylactic Implantation of Implantable Cardioverter-Defibrillator for Japanese Patients With Heart Failure

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Safety, Efficacy and Evidence Base for Use of the Subcutaneous Implantable Cardioverter Defibrillator

Journal of Clinical Medicine
2018English

Improper Implantable Cardioverter Defibrillator Shocks

General Medicine: Open Access
2016English

Examination of Pediatric and Adolescent Patients Who Underwent Implantable Cardioverter Defibrillator Therapy

Pediatric Cardiology and Cardiac Surgery
2013English

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2018English

Exercise-Based Cardiac Rehabilitation for Adult Patients With an Implantable Cardioverter Defibrillator

Cochrane Database of Systematic Reviews
2019English

Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome

Frontiers in Physiology
Physiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy